Atlas Trials

Chemotherapy Followed by Irreversible Electroporation in Patients With Unresectable Locally Advanced Pancreatic Cancer

Clinical trial NCT04093141 · UNKNOWN

Trial details

NCT number
NCT04093141
Sponsor
Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Unresectable Pancreatic Cancer
Start date
2019-05-01
Primary completion
2022-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.